Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 34 clinical trials
Protein Phosphatase 2A Inhibitor in Recurrent Glioblastoma

Background The brain is separated from the rest of the blood stream by the blood-brain barrier. This is like a filter that protects the brain. But is also a challenge when medicines need to get into the brain. Researchers want to give the new drug LB100 to people before brain …

recurrent glioblastoma
glioblastoma multiforme
platelet count
recurrent disease
renal function test
  • 22 views
  • 12 Sep, 2021
  • 1 location
PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)

Background Some people with cancer have solid tumors. Others have refractory leukemia. This doesn t go away after treatment. Researchers want to see if a drug called PLX3397 can shrink tumors or stop them from growing. Objectives To find the highest safe dose and side effects of PLX3397. To see …

solid tumour
measurable disease
graft versus host disease
cancer chemotherapy
ejection fraction
  • 48 views
  • 12 Sep, 2021
  • 1 location
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene

Current chemotherapy for advanced non-small cell lung cancer, not amenable for curative local treatment (surgery or chemoradiotherapy), has a modest life-prolonging effect and can improve quality of life. There is however no potential for long-term cure for these patients. Chemotherapy also produces variable and often significant toxicity. Current retrospective evidence …

chemoradiotherapy
measurable disease
adjuvant chemotherapy
granulocyte count
kidney function test
  • 27 views
  • 07 Nov, 2020
  • 1 location
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

This is a non-interventional observational study aimed at understanding the real world effectiveness of novel agents used in treating multiple myeloma and their impact on patient-reported outcomes. This study will collect information that is already in medical records regarding treatment and diagnostic procedures. Patients are asked to complete questionnaires for …

immunomodulatory imide drug
proteasome inhibitor
line of therapy
  • 289 views
  • 22 Jan, 2021
  • 76 locations